Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome

Life Sciences

Volumn 79, Issue 26, 2006, Pages 2474-2479

  Yamaguchi, Yu ^a   Yamada, Kotaro ^b   Yoshikawa, Noriko ^a   Nakamura, Kazuki ^a   Haginaka, Jun ^a   Kunitomo, Masaru ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^b Use Techno Corporation Co Ltd   (Japan)

Author keywords

Corosolic acid; Metabolic syndrome; Model rats; Oxidative stress

Indexed keywords

3 CHLOROTYROSINE; 3 NITROTYROSINE; COROSOLIC ACID; FATTY ACID; MYELOPEROXIDASE; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; HEALTH CARE; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; LIPID DIET; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; RAT; RAT STRAIN; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; DEOXYGUANOSINE; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; HYPERTENSION; INFLAMMATION; INSULIN; MALE; METABOLIC SYNDROME X; MOLECULAR STRUCTURE; MUSA; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, INBRED SHR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES; TRITERPENES; TYROSINE;

ANIMALIA;

EID: 33750972570     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.08.007     Document Type: Article

References (42)

1. Ahn K.S., Hahm M.S., Park E.J., Lee H.K., and Kim I.H. Corosolic acid isolated from the fruit of Crataegus pinnatifida var. psilosa is a protein kinase C inhibitor as well as a cytotoxic agent. Planta Medica 64 (1998) 468-470
2. Banno N., Akihisa T., Tokuda H., Yasukawa K., Higashihara H., Ukiya M., Watanabe K., and Kimura Y. Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effects. Bioscience, Biotechnology, Biochemistry 68 (2004) 85-90
3. Berry C., Brosnan M.J., Fennell J., Hamilton C.A., and Dominiczak A.F. Oxidative stress and vascular damage in hypertension. Current Opinion in Nephrology Hypertension 10 (2001) 247-255
4. Chen X., Touyz R.M., Park J.B., and Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38 (2001) 606-611
5. Dat N.T., Cai X.F., Rho M.C., Lee H.S., Bae K., and Kim Y.H. The inhibition of diacylglycerol acyltransferase by terpenoids from Youngia koidzumiana. Archives of Pharmacal Research 28 (2005) 164-168
6. Dhalla N.S., Temsah R.M., and Netticadan T. Role of oxidative stress in cardiovascular diseases. Journal of Hypertension 18 (2000) 655-673
7. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391 (1998) 393-397
8. El Midaoui A., and de Champlain J. Champlain prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension 39 (2002) 303-307
9. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
10. Fukushima M., Matsuyama F., Ueda N., Egawa K., Takemoto J., Kajimoto Y., Yonaha N., Miura T., Kaneko T., Nishi Y., Mitsui R., Fijita Y., Yamada Y., and Seino Y. Effect of corosolic acid on postchallenge plasma glucose levels. Diabetes Research and Clinical Practice 73 (2006) 174-177
11. Gaut J.P., Byun J., Tran H.D., Lauber W.M., Carroll J.A., Hotchkiss R.S., Belaaouaj A., and Heinecke J.W. Myeloperoxidase produces nitrating oxidants in vivo. Journal of Clinical Investigation 109 (2002) 1311-1319
12. Kim D.H., Han K.M., Chung I.S., Kim D.K., Kim S.H., Kwon B.M., Jeong T.S., Park M.H., Ahn E.M., and Baek N.I. Triterpenoids from the flower of Campsis grandiflora K. Schum. as human acyl-CoA: cholesterol acyltransferase inhibitors. Archives of Pharmacal Research 28 (2005) 550-556
13. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169 (2003) 203-214
14. Loft S., Vistisen K., Ewertz M., Tjonneland A., Overvad K., and Poulsen H.E. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 13 (1992) 2241-2247
15. Long L., McCabe D.R., and Dolan M.E. Determination of 8-oxoguanine in human plasma and urine by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography. B, Biomedical Sciences and Applications 731 (1999) 241-249
16. Makino A., Skelton M.M., Zou A.P., Roman R.J., and Cowley Jr. A.W. Increased renal medullary oxidative stress produces hypertension. Hypertension 39 (2002) 667-672
17. Miura T., Itoh Y., Kaneko T., Ueda N., Ishida T., Fukushima M., Matsuyama F., and Seino Y. Corosolic acid induces GLUT4 translocation in genetically type 2 diabetic mice. Biological & Pharmaceutical Bulletin 27 (2004) 1103-1105
18. Miura T., Ueda N., Yamada K., Fukushima M., Ishida T., Kaneko T., Matsuyama F., and Seino Y. Antidiabetic effects of corosolic acid in KKAy diabetic mice. Biological & Pharmaceutical Bulletin 29 (2006) 585-587
19. Murakami C., Myoga K., Kasai R., Ohtani K., Kurokawa T., Ishibashi S., Dayrit F., Padolina W.G., and Yamasaki K. Screening of plant constituents for effect on glucose transport activity in Ehrlich ascites tumour cells. Chemical & Pharmaceutical Bulletin (Tokyo) 41 (1993) 2129-2131
20. Nangaku M., Miyata T., Sada T., Mizuno M., Inagi R., Ueda Y., Ishikawa N., Yuzawa H., Koike H., van Ypersele de Strihou C., and Kurokawa K. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in type 2 diabetic nephropathy rat model. Journal of the American Society of Nephrology 14 (2003) 1212-1222
21. Noguchi T., Ikeda K., Sasaki Y., Yamamoto J., Seki J., Yamagata K., Nara Y., Hara H., Kakuta H., and Yamori Y. Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertension Research 24 (2001) 735-742
22. Parhami F., Fang Z.T., Fogelman A.M., Andalibi A., Territo M.C., and Berliner J.A. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. Journal of Clinical Investigation 92 (1993) 471-478
23. Park J.B., Touyz R.M., Chen X., and Schiffrin E.L. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. American Journal of Hypertension 15 (2002) 78-84
24. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
25. Roberts C.K., Vaziri N.D., Wang X.Q., and Barnard R.J. Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension 36 (2000) 423-429
26. Salgo M.G., Bermudez E., Squadrito G.L., and Pryor W.A. Peroxynitrite causes DNA damage and oxidation of thiols in rat thymocytes. Archives of Biochemistry and Biophysics 322 (1995) 500-505
27. Schnackenberg C.G. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 282 (2002) R335-R342
28. Schnackenberg C.G., and Wilcox C.S. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 33 (1999) 424-428
29. Ulker S., McKeown P.P., and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41 (2003) 534-539
30. Vaziri N.D., Wang X.Q., Oveisi F., and Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36 (2000) 142-146
31. Vaziri N.D., Ni Z., Oveisi F., and Trnavsky-Hobbs D.L. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 36 (2000) 957-964
32. Vaziri N.D., Ni Z., Oveisi F., Liang K., and Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39 (2002) 135-141
33. Wassmann S., Laufs U., Stamenkovic D., Linz W., Stasch J.P., Ahlbory K., Rosen R., Bohm M., and Nickenig G. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 105 (2002) 2083-2091
34. Wattanapitayakul S.K., and Bauer J.A. Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications. Pharmacology & Therapeutics 89 (2001) 187-206
35. Wen X., Sun H., Liu J., Wu G., Zhang L., Wu X., and Ni P. Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases. Bioorganic & Medicinal Chemistry Letters 15 (2005) 4944-4948
36. Wilcox C.S. Reactive oxygen species: roles in blood pressure and kidney function. Current Hypertension Reports 4 (2002) 160-166
37. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10
38. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical Medicine 15 (1976) 212-216
39. Yamaguchi Y., Kagota S., Haginaka J., and Kunitomo M. Participation of peroxynitrite in oxidative modification of LDL by aqueous extracts of cigarette smoke. FEBS Letters 512 (2002) 218-222
40. Yamaguchi Y., Matsuno S., Kagota S., Haginaka J., and Kunitomo M. Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin. Atherosclerosis 172 (2004) 259-265
41. Yamaguchi, Y., Yoshikawa, N., Kagota, S., Nakamura, K., Haginaka, J., Kunitomo, M., in press. Elevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome. Nitric Oxide.
42. Yoshida M., Fuchigami M., Nagao T., Okabe H., Matsunaga K., Takata J., Karube Y., Tsuchihashi R., Kinjo J., Mihashi K., and Fujioka T. Antiproliferative constituents from Umbelliferae plants VII. Active triterpenes and rosmarinic acid from Centella asiatica. Biological & Pharmaceutical Bulletin 28 (2005) 173-175